Yahoo
NasdaqGM - Delayed Quote USD

TriSalus Life Sciences, Inc. (TLSI)

3.7000 -0.1600 (-4.15%)
At close: October 30 at 4:00:00 PM EDT
Trade TLSI on Coinbase
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
45,077
45,151
29,431
18,511
12,398
Cost of Revenue
6,406
6,965
4,103
2,605
2,258
Gross Profit
38,671
38,186
25,328
15,906
10,140
Operating Expense
69,180
65,132
61,493
70,381
46,579
Operating Income
-30,509
-26,946
-36,165
-54,475
-36,439
Net Non Operating Interest Income Expense
-4,870
-4,989
-2,686
415
179
Other Income Expense
7,180
-7,285
8,812
-5,294
-10,918
Pretax Income
-28,199
-39,220
-30,039
-59,354
-47,178
Tax Provision
13
7
6
9
9
Net Income Common Stockholders
-57,249
-69,690
-33,233
-63,602
-50,016
Diluted NI Available to Com Stockholders
-57,249
-69,690
-33,233
-63,602
-50,016
Basic EPS
-1.33
-1.84
-1.31
-6.73
-161.55
Diluted EPS
-1.33
-1.84
-1.31
-6.73
-161.55
Basic Average Shares
50,009.5280
37,897.7850
25,331.7530
9,395.7480
309.6090
Diluted Average Shares
50,009.5280
37,897.7850
25,331.7530
9,395.7480
309.6090
Total Operating Income as Reported
-30,509
-26,946
-36,165
-54,475
-36,439
Total Expenses
75,586
72,097
65,596
72,986
48,837
Net Income from Continuing & Discontinued Operation
-28,212
-39,227
-30,045
-59,363
-47,187
Normalized Income
-32,610.6000
-32,398
-39,169
-60,321
-45,565.2066
Interest Income
968
555
404
431
180
Interest Expense
5,838
5,544
3,090
16
1
Net Interest Income
-4,870
-4,989
-2,686
415
179
EBIT
-22,361
-33,676
-26,949
-59,338
-47,177
EBITDA
-21,801
-33,050
-26,205
-58,654
-46,779
Reconciled Cost of Revenue
6,406
6,965
4,103
2,605
2,258
Reconciled Depreciation
560
626
744
684
398
Net Income from Continuing Operation Net Minority Interest
-28,212
-39,227
-30,045
-59,363
-47,187
Total Unusual Items Excluding Goodwill
7,331
-6,829
9,124
958
-2,186
Total Unusual Items
7,331
-6,829
9,124
958
-2,186
Normalized EBITDA
-29,132
-26,221
-35,329
-59,612
-44,593
Tax Rate for Calcs
0.0004
0
0
0
0.0003
Tax Effect of Unusual Items
2,932.4000
0
0
0
-564.2066
12/31/2022 - 2/8/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: